神州泰岳 reported revenue of ¥3.23B for the period ended 2026-06-30, +20.5% year on year. Net income was ¥0.37B, a 11.6% net margin on a 43.9% gross margin. The largest revenue line is 游戏 at 52% of the total. Free cash flow for the period was ¥0.25B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥3.23B | +20.5% |
| Gross profit | ¥1.42B | — |
| Operating income | ¥0.46B | — |
| Net income | ¥0.37B | -25.8% |
| Gross margin | 43.9% | Net margin 11.6% |
| Revenue Q/Q | +30.8% | — |
| Segment | Revenue | Share |
|---|---|---|
| 游戏 | ¥1.67B | 51.6% |
| AI应用与云服务 | ¥1.42B | 43.9% |
| 创新服务 | ¥0.07B | 2.2% |
| 物联网/通讯 | ¥0.06B | 1.8% |
| 其他业务 | ¥0.01B | 0.5% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.81B | 56.1% |
| R&D | ¥0.17B | 5.3% |
| SG&A | ¥0.73B | 22.6% |
| Tax & other | ¥0.09B | 2.7% |
| Item | Amount |
|---|---|
| Total assets | ¥9.14B |
| Total liabilities | ¥1.25B |
| Shareholders' equity | ¥7.89B |
| Equity / assets | 86.3% |
| Operating cash flow | ¥0.27B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥0.25B |
| Cash conversion (OCF / net income) | 124% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
乐普医疗 ・ 南风股份 ・ 探路者 ・ 莱美药业 ・ 汉威科技 ・ 天海防务 ・ 安科生物 ・ ST豆神 ・ 鼎汉技术 ・ 华测检测 ・ 新宁物流 ・ 北陆药业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies